Allergist Says You Need Allergy Shots? What to Consider Before Committing

Quick Answer

If your allergist recommended allergy shots, they're almost certainly right that you need immunotherapy. The question isn't whether — it's which format. 77% of patients quit shots before completing the recommended 3–5 year course (Kiel 2013). Only 23% finish. Sublingual drops use the same immunological mechanism with "near equivalent efficacy, superior SLIT safety profile" (Bernstein 2025). Your allergist may not have mentioned drops — here's why, and what to weigh.

Quick Facts

Detail	Info
Shot completion rate	Only 23% complete 3–5 years (Kiel 2013)
SCIT vs SLIT efficacy	"Near equivalent efficacy, superior SLIT safety profile" (Bernstein 2025)
Allergist SCIT revenue	$1,700–2,700/year per patient vs SLIT $300–600/year
Immunotherapy share of practice revenue	40–60% of allergist practice revenue
Allergists prescribing SLIT	73% have prescribed post-2014; SCIT at 90.7%
Cost	Shots Year 1 = $2,000–4,000 uninsured; allergy drops = $468–1,188/year (2026)

"My Allergist Said I Need Shots — Now I'm Sitting in the Waiting Room Every Week"

Your allergist ran the tests. You're sensitized to dust mites, grass pollen, and cat dander. They recommend allergy shots: weekly injections for the first 6–8 months, then monthly for 3–5 years. You agree because they're the expert.

Then reality sets in. Weekly 90-minute visits (drive, wait, inject, 30-minute observation). You miss work. You rearrange your schedule. You sit in a waiting room next to other people doing the same thing. By month four, you start skipping weeks. By month eight, you're down to showing up sporadically. By year two — if you make it — you're seriously considering quitting.

This is the norm, not the exception. 77% of patients drop out before completing the 3-year minimum for lasting benefit. The immunotherapy your allergist prescribed was correct. The format made it impossible to finish.

Why Most Allergists Recommend Shots Over Drops

Step 1 — Economics strongly favor shots for the practice. Subcutaneous immunotherapy (SCIT) generates $1,700–2,700 per patient per year for the allergist's practice. Sublingual immunotherapy (SLIT) generates $300–600. That's a 3–5× revenue gap per patient. Immunotherapy accounts for 40–60% of allergist practice revenue. Recommending drops instead of shots means recommending a product that generates a fraction of the income.

Step 2 — Training and familiarity default to shots. ACGME allergy/immunology fellowship training does not mandate SLIT education. Allergists learn SCIT as the standard. 90.7% of allergists have administered SCIT; 73% have prescribed SLIT since 2014, but it's a secondary modality in most training programs. Doctors recommend what they know and what they were trained to deliver.

Step 3 — The efficacy gap is smaller than most patients assume. Meta-analyses show near equivalent efficacy between SCIT and SLIT, with SLIT carrying a superior safety profile (Bernstein 2025). SCIT has a slight edge in some head-to-head comparisons, but the clinical difference is small — and completion rates overwhelmingly favor SLIT because patients can take drops at home daily without weekly office visits.

What To Do Next

1. Accept the immunotherapy recommendation — your allergist is right about needing it. If allergy testing confirms IgE sensitization and your symptoms are moderate to severe despite medication, immunotherapy is the only treatment that changes the underlying disease. The recommendation to start is correct regardless of format.

2. Ask your allergist about sublingual drops. Specifically: "I'd like to complete the full 3–5 year course. Given the 77% dropout rate with shots, would sublingual immunotherapy be appropriate for my allergen profile?" Some allergists will prescribe SLIT when asked. Others may refer you to a practice that offers it.

3. If your allergist doesn't offer drops, a 3-minute allergy quiz can assess candidacy with a practice that does. You don't need to fire your allergist. You're choosing a format that you'll actually complete. Cost: allergy drops $39–99/month ($468–1,188/year) vs shots $2,000–4,000 Year 1 uninsured (2026).

When Shots ARE the Better Choice

Shots outperform drops in specific scenarios. Be honest about whether they apply to you:

Venom allergy (bee, wasp, fire ant). SCIT is the gold standard for venom immunotherapy. SLIT for venom is not well-established. If your allergist recommended shots for venom — follow their recommendation.

Severe single-allergen sensitization with asthma. When one dominant allergen drives severe symptoms plus asthma, the slightly higher efficacy of SCIT may matter clinically. If you have asthma controlled on multiple medications and one primary allergen, shots may be worth the logistics.

Full insurance coverage + minimal logistics burden. If your insurance covers SCIT at a $20 copay, the allergist office is 10 minutes from your workplace, and you genuinely can maintain weekly then monthly visits for 3–5 years — shots work well. The 77% dropout rate is an average; if your circumstances support adherence, you may be in the 23% who finish.

🚩 Be realistic. Most people overestimate their ability to maintain weekly medical appointments for years. If you've historically struggled with long-term medical compliance, drops at home may be more honest about your behavior pattern.

Related Issues to Check

• Allergy drops vs allergy shots — Detailed comparison of efficacy, safety, cost, and logistics between SCIT and SLIT. Both work through the same IgG4-mediated tolerance mechanism; the difference is delivery format and what that means for completion.

• How sublingual immunotherapy works — The biological mechanism behind drops: sublingual dendritic cells, IgG4 blocking antibodies, and regulatory T-cell induction. Same immune pathway as shots, different entry point.

• Quit allergy shots — what now? — If you already started shots and stopped (or are about to), this covers whether partial courses provide benefit and how to transition to drops without losing progress.

Frequently Asked Questions

Are allergy drops as effective as allergy shots? Meta-analyses show near equivalent efficacy with a superior safety profile for drops (Bernstein 2025). Shots may have a slight edge in some allergen-specific comparisons, but drops win on real-world completion rates — and incomplete shots provide less benefit than completed drops.

Why didn't my allergist mention drops? Economics and training. SCIT generates 3–5× more practice revenue than SLIT, and ACGME training defaults to SCIT. 73% of allergists have prescribed SLIT post-2014, so the modality is known — it's just not the default recommendation.

Can I switch from shots to drops mid-course? Yes, in many cases. Discuss with your prescribing provider. The immune tolerance built during SCIT carries over, and SLIT can continue building on that foundation.

How much do allergy shots cost without insurance? Year 1 (weekly build-up + monthly maintenance): $2,000–4,000 out of pocket. With insurance, copays of $20–45 per visit add up to $1,000–2,340/year during weekly visits. Drops: $468–1,188/year regardless of insurance status.

Should I trust my allergist's recommendation? Yes — about the need for immunotherapy. The diagnosis and the treatment class are correct. The format preference may reflect practice economics more than your personal best option. Ask questions and make an informed choice about how you receive the treatment.

What if I've already started shots and want to switch? Talk to your allergist or a SLIT provider. Partial SCIT courses still provide some immune modulation. Transitioning to drops lets you continue building tolerance without the weekly office commitment.

Last reviewed: March 2026 · Sources verified against current data

Medically reviewed by Dr. Chet Tharpe, MD · March 2026

Take the Next Step

If your allergist recommended immunotherapy and you want to explore whether drops could work for your specific allergens, a 3-minute allergy quiz identifies your triggers and matches you with the right format.

Take the free 3-minute allergy quiz →